The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Cordido, Fernando ^a,b   Garcia Buela, Jess ^a   Sangiao Alvarellos, Susana ^a,b   Martinez, Teresa ^a   Vidal, Ovidio ^a  

^a Hospital A Corua   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; BLOOD; CARDIOVASCULAR DISEASE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADIPOSE TISSUE; ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 77951646645     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/434562     Document Type: Article

References (52)

1. de Boer H., Blok G.-J., Van der Veen E. A., Clinical aspects of growth hormone deficiency in adults Endocrine Reviews 1995 16 1 63 86
2. Salomon F., Cuneo R. C., Hesp R., Sonksen P. H., The effects op treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency The New England Journal of Medicine 1989 321 26 1797 1803
3. Jorgensen J. O. L., Pedersen S. A., Thuesen L., Beneficial effects of growth hormone treatment in GH-deficient adults The Lancet 1989 1 8649 1221 1225
4. Blow B., Hagmar L., Eskilsson J., Erfurth E. M., Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors The Journal of Clinical Endocrinology Metabolism 2000 85 2 574 584
5. Rosen T., Bengtsson B.-A., Premature mortality due to cardiovascular disease in hypopituitarism The Lancet 1990 336 8710 285 288
6. Tomlinson J. W., Holden N., Hills R. K., Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group The Lancet 2001 357 9254 425 431
7. Evans L. M., Davies J. S., Goodfellow J., Rees J. A. E., Scanlon M. F., Endothelial dysfunction in hypopituitary adults with growth hormone deficiency Clinical Endocrinology 1999 50 4 457 464
8. Markussis V., Beshyah S. A., Fisher C., Sharp P., Nicolaides A. N., Johnston D. G., Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults The Lancet 1992 340 8829 1188 1192
9. Rosen T., Eden S., Larson G., Wilhelmsen L., Bengtsson B.-A., Cardiovascular risk factors in adult patients with growth hormone deficiency Acta Endocrinologica 1993 129 3 195 200 (Pubitemid 23295679)
10. Bollerslev J., Ueland T., Jrgensen A. P., Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH defiency European Journal of Endocrinology 2006 154 4 537 543
11. Burman P., Johansson A. G., Siegbahn A., Vessby B., Karlsson F. A., Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women The Journal of Clinical Endocrinology Metabolism 1997 82 2 550 555 (Pubitemid 27068627)
12. Maison P., Griffin S., Nicoue-Beglah M., Haddad N., Balkau B., Chanson P., Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials The Journal of Clinical Endocrinology Metabolism 2004 89 5 2192 2199
13. Sesmilo G., Biller B. M. K., Llevadot J., Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency: a randomized, controlled clinical trial Annals of Internal Medicine 2000 133 2 111 122
14. Beauregard C., Utz A. L., Schaub A. E., Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study The Journal of Clinical Endocrinology Metabolism 2008 93 6 2063 2071
15. Kanaley J. A., Weatherup-Dentes M. M., Jaynes E. B., Hartman M. L., Obesity attenuates the growth hormone response to exercise The Journal of Clinical Endocrinology Metabolism 1999 84 9 3156 3161
16. Dieguez C., Casanueva F. F., Influence of metabolic substrates and obesity on growth hormone secretion Trends in Endocrinology and Metabolism 1995 6 2 55 59
17. Kopelman P. G., Noonan K., Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women Clinical Endocrinology 1986 24 2 157 164
18. Cordido F., Casanueva F. F., Dieguez C., Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity The Journal of Clinical Endocrinology Metabolism 1989 68 2 290 923
19. Rasmussen M. H., Hvidberg A., Juul A., Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects The Journal of Clinical Endocrinology Metabolism 1995 80 4 1407 1415
20. Kelijman M., Frohman L. A., Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects The Journal of Clinical Endocrinology Metabolism 1988 66 3 489 494
21. Cordido F., Penalva A., Dieguez C., Casanueva F. F., Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity The Journal of Clinical Endocrinology Metabolism 1993 76 4 819 823
22. Furuhata Y., Kagaya R., Hirabayashi K., Development of obesity in transgenic rats with low circulating growth hormone levels: involvement of leptin resistance European Journal of Endocrinology 2000 143 4 535 541
23. Kamel A., Norgren S., Elimam A., Danielsson P., Marcus C., Effects of growth hormone treatment in obese prepubertal boys The Journal of Clinical Endocrinology Metabolism 2000 85 4 1412 1419
24. Franco C., Andersson B., Lnn L., Bengtsson B.-Å., Svensson J., Johannsson G., Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial The Journal of Clinical Endocrinology Metabolism 2007 92 7 2644 2647
25. Mekala K. C., Tritos N. A., Effects of recombinant human growth hormone therapy in obesity in adults: a meta-analysis The Journal of Clinical Endocrinology Metabolism 2009 94 1 130 137
26. Herrmann B. L., Saller B., Stratmann M., Berg C., Mann K., Janssen O. E., Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome Hormone and Metabolic Research 2005 37 1 49 52
27. Makimura H., Stanley T., Mun D., You S. M., Grinspoon S., The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men The Journal of Clinical Endocrinology Metabolism 2008 93 11 4254 4260
28. Utz A. L., Yamamoto A., Hemphill L., Miller K. K., Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women The Journal of Clinical Endocrinology Metabolism 2008 93 7 2507 2514
29. Carmichael J. D., Danoff A., Milani D., GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 5090 Clinical Endocrinology 2006 65 2 169 177
30. Williams T., Berelowitz M., Joffe S. N., Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction The New England Journal of Medicine 1984 311 22 1403 1407
31. Cordido F., Alvarez-Castro P., Isidro M. L., Casanueva F. F., Dieguez C., Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese hypopituitary patients European Journal of Endocrinology 2003 149 2 117 122
32. Lukaski H. C., Bolonchuk W. W., Estimation of body fluid volumes using tretrapolar bioelectrical impedance measurements Aviation Space and Environmental Medicine 1988 59 12 1163 1169
33. Boulier A., Fricker J., Thomasset A.-L., Apfelbaum M., Fat-free mass estimation by the two-electrode impedance method American Journal of Clinical Nutrition 1990 52 4 581 585
34. Lemieux S., Prudhomme D., Bouchard C., Tremblay A., Despres J.-P., A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue American Journal of Clinical Nutrition 1996 64 5 685 693
35. Kratz A., Ferraro M., Sluss P. M., Lewandrowski K. B., Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values The New England Journal of Medicine 2004 351 15 1548 1563
36. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 1985 28 7 412 419
37. Ho K. K. Y., Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia European Journal of Endocrinology 2007 157 6 695 700
38. Jakobsen P. E., Vestergaard P., Falhof J., Laurberg P., Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults Growth Hormone and IGF Research 1999 9 1 18 24
39. Alvarez-Castro P., Isidro M. L., Garcia-Buela J., Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients Clinical Endocrinology 2004 61 2 250 255
40. Cordido F., Fernandez T., Martinez T., Penalva A., Peino R., Casanueva F. F., Dieguez C., Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism The Journal of Clinical Endocrinology Metabolism 1998 83 12 4350 4354
41. Tassone F., Broglio F., Destefanis S., Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity The Journal of Clinical Endocrinology Metabolism 2003 88 11 5478 5483
42. Maccario M., Tassone F., Gianotti L., Effects of recombinant human insulin-like growth factor I administration on the growth hormone (GH) response to GH-releasing hormone in obesity The Journal of Clinical Endocrinology Metabolism 2001 86 1 167 171
43. Johannsson G., Central adiposity as an important confounder in the diagnosis of adult growth hormone deficiency The Journal of Clinical Endocrinology Metabolism 2008 93 11 4221 4223
44. Isidro M. L., Nemina R., Garcia-Buela J., Sangiao-Alvarellos S., Cordido F., Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients Neuroendocrinology Letters 2007 28 5 596 603
45. Laron Z., Ginsberg S., Webb M., Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletionpreliminary report Growth Hormone and IGF Research 2008 18 5 434 438
46. Marchesini G., Moscatiello S., Di Domizio S., Forlani G., Obesity-associated liver disease The Journal of Clinical Endocrinology Metabolism 2008 93 11, supplement 1 s74 s80
47. Clasey J. L., Weltman A., Patrie J., Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors The Journal of Clinical Endocrinology Metabolism 2001 86 8 3845 3852
48. Lanzi R., Manzoni M. F., Andreotti A. C., Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects The Journal of Clinical Endocrinology Metabolism 1997 82 7 2239 2243
49. Melmed S., Insulin suppresses growth hormone secretion by rat pituitary cells Journal of Clinical Investigation 1984 73 5 1425 1433
50. Cordido F., Casanueva F. F., Vidal J. I., Dieguez C., Study of insulin-like growth factor I in human obesity Hormone Research 1991 36 5-6 187 191
51. Utz A. L., Yamamoto A., Sluss P., Breu J., Miller K. K., Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion The Journal of Clinical Endocrinology Metabolism 2008 93 10 4033 4040
52. Nam S. Y., Lee E. J., Kim K. R., Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone International Journal of Obesity 1997 21 5 355 359